Global ETD Search

31	The effect of endogenous tannins on the suitability of sorghum grains for brewing Omolayo, O. O. January 1985 (has links) No description available. 572 Amylase tannin inhibition
32	Inhibition of drug metabolism in vitro and in vivo Tjia, J. F. January 1987 (has links) No description available. 615.1 Drug metabolism inhibition
33	Corrosion inhibition with amides Richardson, J. January 1987 (has links) No description available. 669 Corrosion inhibition study
34	Folate metabolism in Leishmania Scott, D. A. January 1985 (has links) No description available. 572 Folate metabolism/inhibition
35	Titanium-based no-rinse conversion coatings on aluminium alloys Smit, Mascha January 1999 (has links) No description available. 669 Cathodic inhibition; Impedance
36	Novel inhibitors of glutamine synthase Varley, Denise Joyce January 1990 (has links) No description available. 572 Enzyme inhibition; Phosphinothricin
37	Negative priming and inhibition of return in early Alzheimer's disease Vaughan, Frances Lynn January 1999 (has links) No description available. 150 Dementia; Cognitive inhibition
38	Studies on the cestocidal effects of trifluoperazine on Hymenolepis diminuta Hipkiss, J. B. January 1986 (has links) No description available. 615.1 Rat tapeworm inhibition
39	Inhibition of Return in Schizophrenia Hinds, Jeffrey D. (Jeffrey Dale) 08 1900 (has links) The present study was designed to look at inhibition of return within a schizophrenic population for the first time. Inhibition of return is an attentional phenomenon that has been studied with a number of populations, and has been shown to be present in normal individuals. Based on the disattention hypothesis put forth by Cromwell and colleagues (e.g., Cromwell & Dokecki, 1968), it was hypothesized that patients with schizophrenia would show an impaired inhibition of return. Twenty-eight inpatients with schizophrenia, and 19 normal comparisons were evaluated on a visual inhibition of return task. Consistent with hypotheses, schizophrenia patients have significant impairments in inhibition of return compared to normal comparison participants. Further, the relative lack of inhibition of return in the schizophrenic group was found to be strongest to stimuli in the left visual field. These results provide initial support for a reconceptualization of the disattention hypothesis. schizophrenia inhibition of return Schizophrenia.
40	Design and Synthesis of Hybrid Compounds Based on Tacrin/Resveratrol Derivatives Jeřábek, Jakub January 2015 (has links) Charles University in Prague Faculty of Pharmacy in Hradec Králové Department of Pharmaceutical Chemistry and Drug Control Student: Jakub Jeřábek Supervisors: Prof. PharmDr. Martin Doležal, Ph.D. Prof. Maria Laura Bolognesi Title of Thesis: Design and Synthesis of Hybrid Compounds Based on Tacrine/Resveratrol Derivatives Alzheimer's disease (AD) is a progressive neurodegenerative brain disorder, in which a progressive dementia appears. The cause of AD is currently unknown, however, scientific research has revealed several pathological hallmarks - β-amyloid plaques and neurofibrillary tangles. These changes cause gradual disintegration of nerve cells and they change the metabolism in the brain. The current drugs are not able to treat the cause of the disease, being able only to delay the onset of severe symptoms. The basic drugs for AD treatment are acetylcholinesterase (AChE, E.C. 3.1.1.7) inhibitors and, more recently approved, N-methyl- D-aspartate (NMDA) receptor antagonist memantine. These drugs are able to increase cholinergic activity or preventing glutamate excitotoxicity in the patient's brain, thus improving cognitive functions and delaying severe stages of the disease. One of the emerging approaches in drug synthesis represents multi-target-directed ligands (MTDLs). Apart from the ability...

Search results